Sign in

CIK 0001410098

  • Non-accelerated filer

CorMedix Inc.

Sign in to watch
Ticker
CRMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 908-517-9500
Business address
389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ, 07054
Open-market buys, last 90 days
$391,200
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$391,200. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Todisco Joseph +$391K Chief Executive Officer 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-08-13 Mounts Phoebe General Counsel Purchase +2,525 $4.03 $10K 7,200
2020-08-13 Kaplan Myron Director Purchase +15,000 $4.08 $61K 134,734
2020-08-13 Baluch Khoso Chief Executive Officer Purchase +4,830 $4.14 $20K 60,905
2020-08-12 DUNTON ALAN W Director Purchase +5,000 $3.95 $20K 6,250
2020-05-15 Dillione Janet Director Grant or award · Phantom Stock +5,253 5,253
2020-05-15 Kaplan Myron Director Purchase +10,000 $3.85 $39K 119,734
2020-05-11 ARMSTRONG JR. JOHN L. Exec VP of Tech Operations Grant or award · Stock Option (Right to Buy Common Stock) +37,500 $5.63 $211K 37,500
2020-05-11 ARMSTRONG JR. JOHN L. Exec VP of Tech Operations Grant or award · Stock Option (Right to Buy Common Stock) +37,500 $4.08 $153K 37,500
2020-05-11 Masson-Hurlburt Elizabeth EVP, Head of Clinical Ops. Grant or award · Stock Option (Right to Buy Common Stock) +37,500 $5.63 $211K 37,500
2020-05-11 Masson-Hurlburt Elizabeth EVP, Head of Clinical Ops. Grant or award · Stock Option (Right to Buy Common Stock) +37,500 $4.08 $153K 37,500
2020-05-11 Mounts Phoebe General Counsel Grant or award · Stock Option (Right to Buy Common Stock) +50,000 $5.63 $282K 50,000
2020-05-11 Mounts Phoebe General Counsel Grant or award · Stock Option (Right to Buy Common Stock) +50,000 $4.08 $204K 50,000
2020-05-11 David Matthew T EVP, Chief Financial Officer Grant or award · Stock Option (Right to Buy Common Stock) +125,000 $5.63 $704K 125,000
2020-05-11 David Matthew T EVP, Chief Financial Officer Grant or award · Stock Option (Right to Buy Common Stock) +125,000 $4.08 $510K 125,000
2020-03-18 Mounts Phoebe General Counsel Purchase +3,250 $3.05 $10K 4,675
2020-03-18 Baluch Khoso Chief Executive Officer Purchase +3,500 $2.61 $9K 56,075
2020-02-25 Lefkowitz Steven W Director Grant or award · Stock Option (Right to Buy Common Stock) +15,000 $5.63 $84K 15,000
2020-02-25 Dillione Janet Director Grant or award · Stock Option (Right to Buy Common Stock) +15,000 $5.63 $84K 15,000
2020-02-25 Khan Mehmood Director Grant or award · Stock Option (Right to Buy Common Stock) +15,000 $5.63 $84K 15,000
2020-02-25 Mounts Phoebe General Counsel Grant or award · Stock Option (Right to Buy Common Stock) +24,764 $5.63 $139K 24,764

Page 13 of 16 · 301 trades